Andy Williams is a Precision Medicine Franchise Leader at AstraZeneca, where they focus on advancing diagnostics in oncology. They have held significant roles in various organizations, including Director positions at Pfizer Pharmaceuticals and leadership in companion diagnostics at Genentech. Previously, Andy completed postdoctoral research in developmental biology and oncology at St Georges Healthcare NHS Trust and the Institute of Cancer Research, respectively. With a PhD in Pharmacology from the University of Aberdeen, Andy's expertise spans pharmacokinetics, dynamics, and metabolism in the field of cancer therapies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices